With all the talk on here about Ammon, Medcreen, Clarity, ADL, SDX/Mako, RDX/Xeron and many other NE labs, is there any future in the lab industry? NY is a mess with Enzo selling to LC, Xeron being sold, (Sherman Abrahms, all Russina owned labs & Lenco pay to play business model, BRL being BRL, Accurate is gone, and TrueTox bankruptcy rumors. The tox market has not come back due to COVID and NJ Medicaid cuts. NY tox is worthless due to low pay and new drug testing guidelines. Delaware is a Labcorp strong hold. PA and the HealthChoices limitations. Maryland is small and everyone is fighting over the same 40 accounts. Blood testing is tough due to everyone having limited insurance contracts (except L & Q). It seems there is no future unless your name is LabCorp or Quest or you have deep pockets to develop a companion or specialty test (ala ProPhase)
What are everyone's thoughts on this? And please no personal attacks on anyone. Just your honest assessment of the NE lab market. I for one have my resume out there and are looking at healthcare IT and pharma.